Search results for "iOS"

showing 10 items of 8115 documents

Laser Doppler flux and tissue oxygenation of experimental tumours upon local hyperthermia and/or hyperglycaemia

1992

Laser Doppler fluxmetry and oxygen partial pressure (pO2) histography have been applied to investigate the acute effects of hyperthermia (HT) and/or hyperglycaemia (HG) on microcirculatory function and tissue oxygenation of subcutaneous rat tumours growing on the dorsum of the hind foot. The experiments were performed to test whether, and to what extent, the two adjunct treatment modalities applied alone or in combination can modify these therapeutically relevant parameters. Local HT was performed in a saline bath (44 degrees C) for 2 h; HG was induced by i.v. infusion of 40% glucose solution for 2.5 h (blood glucose levels: 35-40 mM during heating). Laser Doppler flux (LDF) in superficial …

Blood GlucoseMaleHyperthermiaCancer Researchmedicine.medical_specialtyRadiosensitizerPathologymedicine.medical_treatmentBiologyLaser doppler fluxOxygen ConsumptionCombined treatmentInternal medicinemedicineAnimalsSalineGlucose tolerance testmedicine.diagnostic_testLasersRats Inbred StrainsHyperthermia InducedNeoplasms ExperimentalGeneral MedicineOxygenationmedicine.diseaseRatsTissue oxygenationOncologyCardiologyFemaleJournal of Cancer Research and Clinical Oncology
researchProduct

Total and Subtypes of Dietary Fat Intake and its Association with Components of the Metabolic Syndrome in a Mediterranean Population at High Cardiova…

2019

Background: The effect of dietary fat intake on the metabolic syndrome (MetS) and in turn on cardiovascular disease (CVD) remains unclear in individuals at high CVD risk. Objective: To assess the association between fat intake and MetS components in an adult Mediterranean population at high CVD risk. Design: Baseline assessment of nutritional adequacy in participants (n = 6560, men and women, 55&ndash

Blood GlucoseMaleMediterranean diethumanosPhysiologyÀcids grassos030204 cardiovascular system & hematologyOverweightDiet Mediterraneanchemistry.chemical_compound0302 clinical medicineRisk Factorsevaluación de riesgosMedicine030212 general & internal medicinemediana edadlípidos2. Zero hungerchemistry.chemical_classificationMetabolic Syndromeeducation.field_of_studyancianoNutrition and Dieteticsdietaresultado del tratamientofood and beveragesMiddle AgedLipidscardiovascular disease risk3. Good healthfat intakeTreatment OutcomeCardiovascular Diseasesdietary fatObesitatFemalemedicine.symptomlcsh:Nutrition. Foods and food supplyPolyunsaturated fatty acidglucosa sanguíneaMediterranean diet cardiovascular disease risk dietary fat fat intake fatty acidsLinoleic acidPopulationdislipidemiasenfermedades cardiovasculareslcsh:TX341-641Risk Assessmentfatty acidsArticle03 medical and health sciencesgrasas dietéticasMediterranean cooking:Ciencias de la Salud::Medicina preventiva [Materias Investigacion]Mediterranean dietCuina mediterràniafactores de riesgoHumansObesitycardiovascular diseaseseducationhiperglucemiaAgedDyslipidemiasbusiness.industryMalalties cardiovascularsHypertriglyceridemiamedicine.diseaseObesityDietary FatsDietCross-Sectional StudieschemistrySpainHyperglycemiaMetabolic syndromebusinessBiomarkersFood Scienceestudios transversalesNutrients
researchProduct

Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to th…

2012

Background: Although the Fat Mass and Obesity (FTO) and Melanocortin-4 Receptor (MC4R) genes have been consistently associated with obesity risk, the association between the obesity-risk alleles with type 2 diabetes is still controversial. In some recent meta-analyses in which significant results have been reported, the associations disappeared after adjustment for body mass index (BMI). However gene-diet interactions with dietary patterns have not been investigated. Our main aim was to analyze whether these associations are modulated by the level of adherence to the Mediterranean Diet (MedDiet). Methods: Case-control study in 7,052 high cardiovascular risk subjects (3,430 type 2 diabetes c…

Blood GlucoseMalelcsh:Diseases of the circulatory (Cardiovascular) systemmodelos logísticoscumplimiento del pacienteMediterranean dietEndocrinology Diabetes and MetabolismhumanosType 2 diabetesfrecuencia génicaMC4RDiet MediterraneanBody Mass IndexNutrigenomicsGene FrequencySurveys and QuestionnairesOdds Ratiomediana edadNutrigeneticsOriginal InvestigationAged 80 and overeducation.field_of_studyancianonutrigenómicaDiabetisdietamodelos linealesDiabetesayunodistribución de la ji al cuadradoFastingMiddle Agedcociente de probabilidades relativasestado nutricionalPhenotypeinteracción gen-ambientediabetes mellitusfenotipoReceptor Melanocortin Type 4FemaleDietaCardiology and Cardiovascular MedicineFTONutrigenòmicamedicine.medical_specialtyglucosa sanguíneaGene-diet interactionsPopulationestudios de casos y controlesAlpha-Ketoglutarate-Dependent Dioxygenase FTONutritional StatusDiabetes mellitusInternal medicineMediterranean dietmedicineGenetic predispositionHumansGenetic Predisposition to Diseaseanálisis multifactorialeducationAgedChi-Square DistributionPolymorphism Geneticbusiness.industryproteínasíndice de masa corporalCase-control studyProteinsnutritional and metabolic diseasespredisposición genética a la enfermedadmedicine.diseaseObesityDietEndocrinologyLogistic ModelsDiabetes Mellitus Type 2lcsh:RC666-701SpainCase-Control StudiesMultivariate AnalysisLinear ModelsPatient ComplianceGene-Environment InteractionbusinessBody mass index
researchProduct

Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione an…

2008

BACKGROUND AND PURPOSE Hypertension is known to be highly prevalent among patients with diabetes and associated with an increased risk of cardiovascular damage. In contrast, relatively few investigations have addressed the prevalence of diabetes among patients with hypertension. The purpose of the present study was to examine the prevalence of type 2 diabetes, the effectiveness of hypertension and diabetes control and the association with other cardiovascular risk factors and previous cardiovascular diseases in a cohort of patients with hypertension referred to 30 hospital outpatient clinics for the treatment of hypertension. METHODS AND PATIENTS Patients were considered as having diabetes …

Blood GlucoseMalemedicine.medical_specialtyhypertensionPhysiologyBlood Pressurediabetes; hypertension; prevalenceType 2 diabetesAmbulatory Care FacilitiesCohort Studieschemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusPrevalenceInternal MedicinemedicineHumansOutpatient clinicAgedCreatinineGlucose tolerance testDiabete di tipo 2 ipertensione arteriosamedicine.diagnostic_testdiabetesbusiness.industryGlucose Tolerance TestMiddle Agedmedicine.diseasediabetes; hypertensionBlood pressureEndocrinologyDiabetes Mellitus Type 2ItalychemistryFemaleMicroalbuminuriaCardiology and Cardiovascular MedicinebusinessCohort study
researchProduct

Comparison of the Effects of Glibenclamide on Metabolic Parameters, GLUT1 Expression, and Liver Injury in Rats With Severe and Mild Streptozotocin-In…

2012

Background and Objective. Glucose transport via GLUT1 protein could be one of additional mechanisms of the antidiabetic action of sulfonylureas. Here, the GLUT1 gene and the protein expression was studied in rats in the course of severe and mild streptozotocin-induced diabetes mellitus and under glibenclamide treatment. Material and Methods. Severe and mild diabetes mellitus was induced using different streptozotocin doses and standard or high fat chow. Rats were treated with glibenclamide (2 mg/kg daily, per os for 6 weeks). The therapeutic effect of glibenclamide was monitored by measuring several metabolic parameters. The GLUT1 mRNA and the protein expression in the kidneys, heart, and l…

Blood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentGene ExpressionDiabetes Mellitus ExperimentalGlibenclamideInternal medicineDiabetes mellitusGlyburideInsulin SecretionmedicineAnimalsHypoglycemic AgentsInsulinRats WistarLiver injuryGlucose Transporter Type 1Kidneybiologybusiness.industryInsulinGlucose transporternutritional and metabolic diseasesGeneral Medicinemedicine.diseaseStreptozotocinRatsSulfonylurea Compoundsmedicine.anatomical_structureEndocrinologyLiverProtein Biosynthesisglibenclamide; GLUT1; kidney; streptozotocin; expressionbiology.proteinGLUT1businessmedicine.drugMedicina; Volume 48; Issue 10; Pages: 78
researchProduct

Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats

2010

Abstract Mildronate is a cardioprotective drug, the mechanism of action of which is based on the regulation of l -carnitine concentration. We studied the metabolic effects of treatment with mildronate, metformin and a combination of the two in the Zucker rat model of obesity and impaired glucose tolerance. Zucker rats were p.o. treated daily with mildronate (200 mg/kg), metformin (300 mg/kg), and a combination of both drugs for 4 weeks. Weight gain and plasma metabolites reflecting glucose metabolism were measured. The expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ and target genes was measured in rat heart and liver tissues. Each treatment decreased the blood …

Blood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentPeroxisome proliferator-activated receptorCarbohydrate metabolismImpaired glucose toleranceEatingInternal medicinemedicineAnimalsHypoglycemic AgentsInsulinPPAR alphaLactic AcidObesityRNA MessengerCarnitineCell NucleusPharmacologychemistry.chemical_classificationbusiness.industryMyocardiumInsulinBody WeightLipid Metabolismmedicine.diseaseMetforminRatsRats ZuckerMetforminPPAR gammaDrug CombinationsEndocrinologyGene Expression RegulationMechanism of actionchemistryCarnitine biosynthesismedicine.symptombusinessMethylhydrazinesmedicine.drugEuropean Journal of Pharmacology
researchProduct

Glucose and Erythrocyte ATP: Distinctive Effects of Dipyridamole and of Ticlopidine

1987

This experiment suggests the following points: 1. Erythrocytes in control patients and in atherosclerosis patients seem to have a variable grade of affinity for adenosine and for plasma glucose. This variable grade seems to fix the level of the adenosine triphosphate (ATP) reserves and induces the erythrocytes' deformability. 2. The drop in the level of ATP reserves that induces the poor deformability of the erythrocytes in atherosclerosis patients would appear to be caused by two consecutive shortages: first a shortage that seems to be related to a deficiency of erythrocyte adenosine as the ATP shortage disappears with dipyridamole treatment and then a shortage induced by the lack of eryt…

Blood Glucosemedicine.medical_specialtyAdenosineErythrocytesTiclopidineArteriosclerosismedicine.medical_treatmentEconomic shortage030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compoundAdenosine Triphosphate0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineTiclopidineChemotherapyPlasma glucosebusiness.industryDipyridamoleAdenosineDipyridamoleRed blood cellEndocrinologymedicine.anatomical_structurechemistryDrug Therapy CombinationCardiology and Cardiovascular MedicinebusinessAdenosine triphosphatemedicine.drugAngiology
researchProduct

A Multiple Local Models Approach to Accuracy Improvement in Continuous Glucose Monitoring

2011

Continuous glucose monitoring (CGM) devices estimate plasma glucose (PG) from measurements in compartments alternative to blood. The accuracy of currently available CGM is yet unsatisfactory and may depend on the implemented calibration algorithms, which do not compensate adequately for the differences of glucose dynamics between the compartments. Here we propose and validate an innovative calibration algorithm for the improvement of CGM performance.CGM data from GlucoDay(®) (A. Menarini, Florence, Italy) and paired reference PG have been obtained from eight subjects without diabetes during eu-, hypo-, and hyperglycemic hyperinsulinemic clamps. A calibration algorithm based on a dynamic glo…

Blood Glucosemedicine.medical_specialtyCalibration (statistics)Endocrinology Diabetes and MetabolismMonitoring Ambulatory030209 endocrinology & metabolismBiosensing TechniquesAccuracy improvementSensitivity and Specificity01 natural sciencesGlobal model03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineBlood Glucose Self-MonitoringDiabetes MellitusmedicineHumansGlucose dynamicsPlasma glucoseContinuous glucose monitoringbusiness.industryBlood Glucose Self-Monitoring010401 analytical chemistryReproducibility of ResultsPattern recognition0104 chemical sciencesMedical Laboratory TechnologyEndocrinologyCalibration algorithmArtificial intelligencebusinessAlgorithmsDiabetes Technology & Therapeutics
researchProduct

Biosimilars and Novel Insulins.

2019

Background Insulin therapy is the mainstay of treatment for type 1 diabetes and may be necessary in type 2 diabetes. Current insulin analogues present a more physiological profile, are effective, and with less risk of hypoglycemia, but they are expensive. Biosimilar insulins should offer the advantages of insulin analogues at reduced costs. In addition, current rapid-acting insulin analogues are not fast enough to control excessive postprandial glucose excursions in many patients. Areas of uncertainty Biosimilar insulins demonstrated that are safe and effective, but interchangeability and automatic substitution remain an issue. Ultrafast-acting insulins should reduce postprandial hyperglyce…

Blood Glucosemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentInsulin GlargineType 2 diabetes030204 cardiovascular system & hematologyHypoglycemiaInsulin aspart03 medical and health sciences0302 clinical medicinemedicineInsulin lisproHumansHypoglycemic AgentsPharmacology (medical)030212 general & internal medicineIntensive care medicineBiosimilar PharmaceuticalsRandomized Controlled Trials as TopicPharmacologyGlycated HemoglobinType 1 diabetesInsulin Lisprobusiness.industryInsulin glargineInsulinnutritional and metabolic diseasesBiosimilarGeneral Medicinemedicine.diseaseDiabetes Mellitus Type 1Diabetes Mellitus Type 2Hyperglycemiabusinessmedicine.drugAmerican journal of therapeutics
researchProduct

The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease

2018

Commensal gut microbiota have recently been implicated in cardiovascular disease (CVD) and cerebrovascular disease. Atherosclerotic plaque formation depends on the colonization status of the host. In addition to host nutrition and the related microbiota-dependent metabolic changes, activation of innate immune pathways triggers the development of atherosclerosis and supports arterial thrombosis. Gnotobiotic mouse models have uncovered that activation of Toll-like receptor-2 by gut microbial ligands supports von Willebrand factor-integrin mediated platelet deposition to the site of vascular injury. Depending on nutritional factors, the microbiota-derived choline-metabolite trimethylamine N-ox…

Blood Platelets0301 basic medicineIntegrinsEmerging riskImmunologyDiseaseBiologyGut floradigestive systemMethylaminesMice03 medical and health sciencesVon willebrandRisk Factorsvon Willebrand FactormedicineAnimalsHumansImmunology and AllergyPlateletSymbiosisInnate immune systemInfant NewbornInfantThrombosisAtherosclerosisbiology.organism_classificationmedicine.diseaseThrombosisImmunity InnatePlaque AtheroscleroticToll-Like Receptor 2Gastrointestinal MicrobiomeCerebrovascular Disorders030104 developmental biologyCardiovascular DiseasesArterial thrombusImmunologyEuropean Journal of Immunology
researchProduct